Imigran Ftab (Sumatriptan)

Sumatriptan acts as an agonist at 5‑HT1B and 5‑HT1D receptors. Stimulation of 5‑HT1B receptors causes constriction of dilated cranial blood vessels, while activation of 5‑HT1D receptors inhibits release of inflammatory neuropeptides, together reducing migraine pain.

The dose of Imigran Ftab is individualized by a qualified prescriber based on the patient’s clinical condition, prior response, and tolerability. Physicians typically select an appropriate tablet strength and timing according to established migraine treatment guidelines.

Safety data for sumatriptan in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and under medical supervision.

To order Imigran Ftab, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Imigran Ftab belongs to the triptan class, which provides rapid migraine relief through serotonin receptor activation. Compared with non‑triptan analgesics, triptans target the underlying vascular and neurogenic mechanisms of migraine, often resulting in faster and more complete symptom resolution.

Store Imigran Ftab at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Imigran Ftab is taken orally with a full glass of water. The tablet should be swallowed whole and not chewed or crushed. It is usually taken at the first sign of a migraine attack, as directed by a healthcare professional.

Serious risks include serotonin syndrome when combined with other serotonergic drugs, coronary vasospasm leading to chest pain or myocardial ischemia, and rare cerebrovascular events such as stroke. Patients should seek immediate medical attention if they experience severe chest discomfort, sudden neurological changes, or signs of an allergic reaction.

Imigran Ftab is contraindicated in individuals with known hypersensitivity to sumatriptan or other triptans, uncontrolled hypertension, recent myocardial infarction or stroke, and certain severe cardiovascular disorders. It should also be avoided in patients taking monoamine oxidase inhibitors within the past two weeks.